China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,145,721 | $137,159 | $107,592 | $86,031 |
| Dep. & Amort. | $68,735 | $8,521 | $8,736 | $9,838 |
| Deferred Tax | $0 | $0 | $0 | -$43,157 |
| Stock-Based Comp. | $0 | $0 | $0 | $5 |
| Change in WC | $221,959 | -$23,684 | $43,161 | $6,678 |
| Other Non-Cash | -$473,280 | $18,622 | $19,067 | $60,719 |
| Operating Cash Flow | $963,135 | $140,619 | $178,555 | $120,143 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$140,112 | -$20,418 | -$19,272 | -$14,470 |
| Net Acquisitions | $983 | $0 | $521 | $14,062 |
| Inv. Purchases | -$844,997 | -$73,566 | -$44,658 | -$57,181 |
| Inv. Sales/Matur. | $527,613 | $75,056 | $45,651 | $58,584 |
| Other Inv. Act. | $184,403 | $2,875 | $546 | $1,984 |
| Investing Cash Flow | -$272,110 | -$16,052 | -$17,213 | $2,977 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $30,000 | $42,442 | -$1,114 | -$369,319 |
| Stock Issued | $0 | $0 | $0 | $3,663 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$407,916 | -$44,699 | -$35,048 | -$71,294 |
| Other Fin. Act. | -$14,559 | -$24,480 | -$965 | $688,290 |
| Financing Cash Flow | -$392,475 | -$26,738 | -$37,127 | -$127,876 |
| Forex Effect | -$47,173 | $6,154 | $6,325 | -$6,514 |
| Net Chg. in Cash | $251,377 | $104,800 | $65,585 | $10,909 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,888,776 | $728,761 | $659,707 | $648,798 |
| End Cash | $6,140,153 | $830,092 | $725,292 | $659,707 |
| Free Cash Flow | $823,023 | $120,201 | $159,284 | $105,673 |